We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
MBIA
MBI
$224M
| $113 | ﹤0.01% |
26
| – | – |
2023 Q4
6 quarters
|
|
3427
Stellus Capital Investment Corp
SCM
$201M
| $112 | ﹤0.01% |
8
| – | – |
2024 Q4
2 quarters
|
|
3428
Agenus
AGEN
$294M
| $110 | ﹤0.01% |
+24
| New | +$83 |
2025 Q2
0 quarters
|
|
3429
DELISTED
Adverum Biotechnologies
ADVM
| $108 | ﹤0.01% |
50
| – | – |
2020 Q1
21 quarters
|
|
3430
Octave Specialty Group
OSG
$212M
| $107 | ﹤0.01% |
+15
| New | +$112 |
2025 Q2
0 quarters
|
|
3431
Tilray
TLRY
$464M
| $105 | ﹤0.01% |
25
| – | – |
2018 Q3
27 quarters
|
|
3432
Americas Gold and Silver
USAS
$1.25B
| $105 | ﹤0.01% |
52
| – | – |
2022 Q1
13 quarters
|
|
3433
Serve Robotics
SERV
$298M
| $103 | ﹤0.01% |
9
-299
| -97% | -$2.63K |
2024 Q3
3 quarters
|
|
3434
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.18B
| $102 | ﹤0.01% |
+5
| New | +$99 |
2025 Q2
0 quarters
|
|
3435
Borr Drilling
BORR
$1.44B
| $101 | ﹤0.01% |
55
-244
| -82% | -$461 |
2022 Q4
10 quarters
|
|
3436
8x8 Inc
EGHT
$290M
| $98 | ﹤0.01% |
50
| – | – |
2024 Q3
3 quarters
|
|
3437
MicroCloud Hologram
HOLO
$31M
| $98 | ﹤0.01% |
+20
| New | +$208 |
2025 Q2
0 quarters
|
|
3438
F&G Annuities & Life
FG
$2.54B
| $97 | ﹤0.01% |
3
-142
| -98% | -$4.71K |
2024 Q4
2 quarters
|
|
3439
Vista Energy
VIST
$7.74B
| $96 | ﹤0.01% |
+2
| New | +$95 |
2025 Q2
0 quarters
|
|
3440
DELISTED
ZimVie
ZIMV
| $94 | ﹤0.01% |
10
-91
| -90% | -$831 |
2022 Q1
13 quarters
|
|
3441
Zeta Global
ZETA
$8.1B
| $93 | ﹤0.01% |
6
-55
| -90% | -$730 |
2024 Q3
3 quarters
|
|
3442
Renaissance IPO ETF
IPO
$139M
| $90 | ﹤0.01% |
+2
| New | +$82 |
2025 Q2
0 quarters
|
|
3443
Acco Brands
ACCO
$413M
| $82 | ﹤0.01% |
23
-326
| -93% | -$1.21K |
2021 Q1
17 quarters
|
|
3444
Liberty Global Class A
LBTYA
$2.79B
| $80 | ﹤0.01% |
8
| – | – |
2021 Q3
15 quarters
|
|
3445
KKR Real Estate Finance Trust
KREF
$343M
| $79 | ﹤0.01% |
9
| – | – |
2022 Q4
10 quarters
|
|
3446
Star Holdings Shares of Beneficial Interest
STHO
$96.8M
| $78 | ﹤0.01% |
10
| – | – |
2023 Q1
9 quarters
|
|
3447
Phibro Animal Health
PAHC
$1.54B
| $77 | ﹤0.01% |
3
-13
| -81% | -$283 |
2025 Q1
1 quarter
|
|
3448
Ramaco Resources Class B
METCB
$257M
| $74 | ﹤0.01% |
10
| – | – |
2024 Q4
2 quarters
|
|
3449
Loop Industries
LOOP
$16.5M
| $71 | ﹤0.01% |
50
| – | – |
2018 Q3
27 quarters
|
|
3450
Beyond Meat
BYND
$117M
| $70 | ﹤0.01% |
+1
| New | +$87 |
2025 Q1
1 quarter
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.